journal
https://read.qxmd.com/read/38682125/frailty-sarcopenia-and-nutrition-in-patients-with-cirrhosis
#1
JOURNAL ARTICLE
Jennifer C Lai
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682124/exploring-cardiovascular-comorbidities-and-inflammatory-bowel-disease
#2
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682123/update-on-treatment-for-metabolic-dysfunction-associated-steatohepatitis-cirrhosis
#3
JOURNAL ARTICLE
William Alazawi
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682122/cardiovascular-comorbidities-and-inflammatory-bowel-disease-causes-and-consequences
#4
JOURNAL ARTICLE
Preetika Sinh, Raymond K Cross
Patients with inflammatory bowel disease (IBD) have an increased risk of cardiovascular disease (CVD) such as myocardial infarction and stroke. CVD in patients with IBD might occur in those with younger age and active disease, which are not traditional risk factors of CVD. Atherosclerotic CVD (ASCVD) and IBD are both proinflammatory conditions, and the underlying chronic inflammation might drive ASCVD risk. Decreasing inflammation might reduce this risk; however, data are limited. IBD medications can increase or decrease ASCVD risk...
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682121/perianal-fistulas-in-patients-with-crohn-s-disease
#5
JOURNAL ARTICLE
David A Schwartz
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682120/hyperbaric-oxygen-therapy-for-refractory-perianal-crohn-s-disease-a-case-report
#6
JOURNAL ARTICLE
June Tome, Sunanda V Kane
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38682119/managing-ibs-c-focus-on-symptom-control
#7
JOURNAL ARTICLE
Brian E Lacy
No abstract text is available yet for this article.
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680175/appeal-letter-templates
#8
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680174/current-and-emerging-treatments-for-autoimmune-hepatitis
#9
JOURNAL ARTICLE
Ethan M Weinberg
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680173/hemostatic-techniques-in-the-management-of-gastrointestinal-bleeding
#10
JOURNAL ARTICLE
Seth A Gross
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680172/corticosteroid-free-remission-in-patients-with-inflammatory-bowel-disease
#11
JOURNAL ARTICLE
Bruno C├ęsar da Silva
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680171/current-status-of-the-liver-imaging-reporting-and-data-system-in-hepatocellular-carcinoma
#12
JOURNAL ARTICLE
Victoria Chernyak
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680170/best-practices-for-helicobacter-pylori-management
#13
JOURNAL ARTICLE
David Y Graham
For decades, antimicrobial therapy for Helicobacter pylori infection has been given empirically, and the results of therapy (success or failure) have either not been confirmed or when confirmed have not been used to modify prescribing behavior. These practices coupled with increasing antibiotic resistance have resulted in low cure rates overall. Susceptibility testing for H pylori has increasingly become available, especially in the United States. Availability of susceptibility-based therapy has encouraged adoption of the principles of antimicrobial stewardship for H pylori infection (eg, limiting antibiotic choice to antibiotics for which the infection is susceptible given at optimal doses, formulations, frequency of administration, and duration)...
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680169/artificial-intelligence-in-esophageal-diseases
#14
JOURNAL ARTICLE
Cadman L Leggett
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680168/update-on-the-screening-diagnosis-and-management-of-cholangiocarcinoma
#15
JOURNAL ARTICLE
Sudha Kodali, Ashton A Connor, Elizabeth W Brombosz, R Mark Ghobrial
Cholangiocarcinoma (CCA) is a neoplasm of the biliary tract that has become increasingly prevalent throughout the world. Common risk factors for developing CCA include cirrhosis, primary sclerosing cholangitis, and trematode fluke infestation, although there are no set screening guidelines in high-risk groups. Lesions are typically identified via cross-sectional imaging and/or elevated serum carbohydrate antigen 19-9 levels, often followed by cytology or brushings with fluorescence in situ hybridization for confirmation...
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38680167/applications-of-artificial-intelligence-in-esophageal-diseases
#16
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
March 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38414915/exploring-vaccination-in-patients-with-inflammatory-bowel-disease
#17
JOURNAL ARTICLE
Gary R Lichtenstein
No abstract text is available yet for this article.
February 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38414914/a-review-of-new-concepts-in-iron-overload
#18
JOURNAL ARTICLE
Aalam Sohal, Kris V Kowdley
Iron overload disorders are conditions that can lead to increased body iron stores and end-organ damage in affected organs. Increased iron deposition most commonly occurs in the liver, heart, endocrine system, joints, and pancreas. Iron overload disorders may be caused by genetic or acquired causes (transfusion, dyserythropoiesis, and chronic liver disease). The HFE gene C282Y homozygous mutation is the most common cause of hereditary hemochromatosis (HH). Other genes implicated in HH include TFR2 , HAMP, HJV, and SLC40A1 ...
February 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38414913/reviewing-recommendations-for-vaccines-and-health-care-maintenance-in-patients-with-inflammatory-bowel-disease
#19
JOURNAL ARTICLE
Francis A Farraye
No abstract text is available yet for this article.
February 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38414912/esophagogastric-junction-outflow-obstruction-a-diagnosis-in-evolution
#20
JOURNAL ARTICLE
Kristle Lee Lynch, Joan Chen, Anand Jain, Rena Yadlapati
Esophagogastric junction outflow obstruction (EGJOO) is a rapidly evolving diagnosis that can represent early or variant achalasia. Since the publication of the Chicago Classification version 4.0, the criteria for this diagnosis have been more stringent. Currently, the criteria include an elevated median integrated relaxation pressure (IRP) in both the supine and upright positions, elevated intrabolus pressure in at least 20% of supine swallows, dysphagia and/or chest pain, as well as an abnormal timed barium esophagram and/or impedance planimetry testing...
February 2024: Gastroenterology & Hepatology
journal
journal
41233
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.